Leukaemic dendritic cell vaccination for patients with acute myeloid leukaemia [1]

British Journal of Haematology

Volumn 134, Issue 4, 2006, Pages 445-446

  Houtenbos, I ^a   Westers, T M ^a   Ossenkoppele, G J ^a   Van De Loosdrecht, A A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukaemia; Dendritic cells; Immunotherapy

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CALCIMYCIN; CANCER VACCINE; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; DENDRITIC CELL VACCINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 4; LEUKEMIA ANTIGEN; NEUTRALIZING ANTIBODY; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; BLAST CELL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL TRIAL; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENCY; FEASIBILITY STUDY; HUMAN; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL; LYMPHOCYTE FUNCTION; MEDICAL PARAMETERS; MICROENVIRONMENT; MONOCYTE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TREATMENT RESPONSE; VACCINATION;

CELL CULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOCYTIC, ACUTE;

EID: 33746074415     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06196.x     Document Type: Letter

References (7)

1. Houtenbos, I., Westers, T.M., Ossenkoppele, G.J. & van de Loosdrecht, A.A. (2003) Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia. Leukemia, 17, 1683-1684.
2. Houtenbos, I., Westers, T.M., de Gruijl, T.D., Scheper, R.J., Ossenkoppele, G.J. & van de Loosdrecht, A.A. (2004) TNF-alpha receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells. Leukemia, 18, 1149-1153.
3. Houtenbos, I., Westers, T.M., Ossenkoppele, G.J. & van de Loosdrecht, A.A. (2005) Presence of a Flt-3 internal tandem duplication in AML blasts predicts inhibition of differentiation towards leukemic dendritic cells. Blood, 106, 2753.
4. Houtenbos, I., Westers, T.M., Hess, C.J., Waisfisz, Q., Gundy, C., Ossenkoppele, G.J. & van de Loosdrecht, A.A. (2006a) Flt-3 internal tandem duplication hampers differentiation of AML blasts toward leukaemia dendritic cells. Leukemia (in press).
5. Houtenbos, I., Westers, T.M., Ossenkoppele, G.J. & van de Loosdrecht, A.A. (2006b) Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia. Haematologica, 91, 348-355.
6. Mohty, M., Isnardon, D., Blaise, D., Mozziconacci, M.J., Lafage-Pochitaloff, M., Briere, F., Gastaut, J.A., Olive, D. & Gaugler, B. (2002) Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia, 16, 2267-2274.
7. Roddie, H., Klammer, M., Thomas, C., Thomson, R., Atkinson, A., Sproul, A., Waterfall, M., Samuel, K., Yin, J., Johnson, P. & Turner, M. (2006) Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia. British Journal of Haematology, 133, 152-157.